Below are the most recent publications written about "Ovarian Neoplasms" by people in Profiles.
-
Minneci PC, Bergus KC, Lutz C, Aldrink J, Bence C, Breech L, Dillon PA, Downard C, Ehrlich PF, Fallat M, Fraser JD, Grabowski J, Helmrath M, Hertweck P, Hewitt G, Hirschl RB, Kabre R, Lal DR, Landman M, Leys C, Mak G, Markel T, Pressey J, Raiji M, Rymeski B, Saito J, Sato TT, St Peter SD, Cooper J, Deans K. Reducing Unnecessary Oophorectomies for Benign Ovarian Neoplasms in Pediatric Patients. JAMA. 2023 10 03; 330(13):1247-1254.
-
Moore JA, Chen KT, Madison R, Newberg JY, Fleischmann Z, Wang S, Sharaf R, Murugesan K, Fendler BJ, Hughes J, Schrock AB, Hegde PS, Oxnard GR, Fabrizio D, Frampton GM, Antonarakis ES, Sokol ES, Jin DX. Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response. JCO Precis Oncol. 2023 Sep; 7:e2300093.
-
Mulchandani V, Banerjee A, Vadlamannati AV, Kumar S, Das Sarma J. Connexin 43 trafficking and regulation of gap junctional intercellular communication alters ovarian cancer cell migration and tumorigenesis. Biomed Pharmacother. 2023 Mar; 159:114296.
-
Knaus ME, Onwuka AJ, Abouelseoud NM, Bergus KC, Breech LL, Brito KS, Dekonenko C, Hertweck SP, Hong HY, Menon S, Merritt DF, Schikler AG, Senapati N, Smith YR, Strickland JL, Truehart AI, Minneci PC, Hewitt GD. Recurrence Rates for Pediatric Benign Ovarian Neoplasms. J Pediatr Adolesc Gynecol. 2023 Apr; 36(2):160-166.
-
Herzog TJ, Vergote I, Gomella LG, Milenkova T, French T, Tonikian R, Poehlein C, Hussain M. Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective. Eur J Cancer. 2023 Jan; 179:136-146.
-
Gil LA, Lutz CM, Dillon PA, Downard CD, Ehrlich PF, Fallat ME, Fraser JD, Grabowski JE, Helmrath MA, Hertweck SP, Hirschl RB, Kabre R, Lal DR, Landman MP, Lawrence AE, Leys CM, Mak GZ, Markel TA, Raiji MT, Rymeski B, Saito JM, Sato TT, St Peter SD, Stafford LMC, Deans KJ, Minneci PC, Hewitt GD, Aldrink JH. Use and Accuracy of Intraoperative Frozen Section Analysis for Ovarian Masses in Children and Adolescents. J Pediatr Adolesc Gynecol. 2023 Apr; 36(2):155-159.
-
Thakker S, Loeb S, Giri VN, Bjurlin MA, Matulewicz RS. Attitudes, Perceptions, and Use of Cancer-based Genetic Testing Among Healthy U.S. Adults and Those With Prostate or Breast/Ovarian Cancer. Urol Pract. 2023 Jan; 10(1):26-32.
-
Korzun T, Moses AS, Kim J, Patel S, Schumann C, Levasseur PR, Diba P, Olson B, Rebola KGO, Norgard M, Park Y, Demessie AA, Eygeris Y, Grigoriev V, Sundaram S, Pejovic T, Brody JR, Taratula OR, Zhu X, Sahay G, Marks DL, Taratula O. Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia. Small. 2022 11; 18(44):e2204436.
-
Knaus ME, Onwuka AJ, Abouelseoud NM, Breech LL, Brito KS, Dekonenko C, Hertweck SP, Hong HY, Lawrence AE, Menon S, Merritt DF, Schikler AG, Senapati N, Smith YR, Strickland JL, Truehart AI, Minneci PC, Hewitt GD. Failure of Operative Therapy after Ovarian-Sparing Surgery for Pediatric Benign Ovarian Neoplasms: A Retrospective Review. J Pediatr Adolesc Gynecol. 2022 Dec; 35(6):702-706.
-
Tomar S, Zhang J, Khanal M, Hong J, Venugopalan A, Jiang Q, Sengupta M, Miettinen M, Li N, Pastan I, Ho M, Hassan R. Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors. Mol Cancer Ther. 2022 07 05; 21(7):1195-1206.